Cargando…
A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare
We report a case of a man with chronic hepatitis C infection treated with remdesivir for COVID-19, resulting in lowered HCV viral load, followed by a rebound after its discontinuation. Concomitant treatment with tocilizumab possibly caused loss of anti-HBs.
Autores principales: | da Cunha, Maria Ribeiro, Rodrigues, Inês Coelho, Trigueiros, Frederico, Freitas, Luís Carlos, Braz, Sandra, Cota Medeiros, Fábio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989155/ https://www.ncbi.nlm.nih.gov/pubmed/33880393 http://dx.doi.org/10.1093/ofid/ofab100 |
Ejemplares similares
-
A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis
por: Cunha, Maria, et al.
Publicado: (2020) -
Organizing pneumonia and COVID-19: A report of two cases
por: Simões, Joana Paiva, et al.
Publicado: (2021) -
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
por: Liu, Chun Jen, et al.
Publicado: (2021) -
Simvastatin Posttreatment Controls Inflammation and Improves Bacterial Clearance in Experimental Sepsis
por: de Jesus Oliveira, Flora Magno, et al.
Publicado: (2020) -
Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience
por: Sabba, Antonio, et al.
Publicado: (2023)